|
|
|
|
|
|
Biography
Professor of Medicine, Division of Infectious Diseases
Director, Transplant Infectious Disease Program
Director, Infectious Diseases Clinical Research Center
Oregon Health and Science University
Portland, Oregon
Kieren A. Marr received a medical degree from Hahnemann University School of Medicine in Philadelphia, Pennsylvania. Her advanced training included an internship and residency in internal medicine at Duke University School of Medicine (where she served as Assistant Chief Resident) and a fellowship in infectious diseases at the University of Washington and Fred Hutchinson Cancer Research Center (UW/FHCRC) in Seattle, Washington. She was faculty at UW/FHCRC for 10 years prior to moving to Oregon Health and Science University. In addition, Dr. Marr serves as Affiliate Investigator in the Clinical Research Division at FHCRC.
Board certified in internal medicine and infectious diseases, Dr. Marr holds membership in the Infectious Disease Society of America, International Society for Human and Animal Mycology, American Society of Transplantation, and several other professional societies. Additionally, Dr. Marr serves on several committees and advisory bodies, including the Steering Committee for the Centers for Disease Control and Prevention TRANSNET Fungal Infection Surveillance project, and the NIH study section for antimicrobial agent development and resistance.
Dr. Marr is well published, with articles in several journals, including the New England Journal of Medicine, Blood, and Journal of Immunology. She has written chapters in several books and served as Editor for the book Diagnosis of Fungal Infections and Section Editor for Infectious Diseases (Cohen and Powderly, 3rd edition). Active in research and research training, Dr. Marr has served as the principal investigator for several federally and commercially supported studies. She twice received a National Institutes of Health Clinical Research Loan Repayment Award. Dr. Marr is a highly sought invited speaker.
Professor of Medicine
Associate Professor of Molecular Genetics and Microbiology
Duke University Medical Center
Durham, North Carolina
John Perfect earned a medical degree at the Medical College of Ohio, in Toledo (from which he also received the 2003 Distinguished Alumnus Award). He completed an internship at Riverside Methodist Hospital in Columbus, Ohio, a medical residency at the University of Michigan Medical Center in Ann Arbor, and a fellowship in infectious diseases at Duke University Medical Center under the mentorship of Dr. David Durack.
Dr. Perfect is active in professional societies and holds membership in the American Federation of Clinical Research, International Society for Human and Animal Mycology, and the Immunocompromised Host Society. He is a Fellow of the American Society of Microbiology and the Infectious Diseases Society of America (IDSA). Additionally, Dr. Perfect serves on the Pharmacy and Therapeutics Antibiotic Subcommittee (Duke Hospital), Mycoses Study Group, and the Duke University Medical Center Awards Committee. He is Chairman of the Revision of IDSA Cryptococcosis Treatment Guidelines Committee.
Dr. Perfect has authored hundreds of articles, abstracts, and letters. He serves on the editorial boards of Infectious Diseases in Clinical Practice and Expert Reviews of Antifungal Therapy, is Associate Editor of Antifungal Drug Resistance Update, and Editor of Journal of Invasive Fungal Infections. Dr. Perfect's research focuses on several aspects of medical mycology, including antifungal agents in animal models of Candida and cryptococcal infections. Dr. Perfect also studies the molecular pathogenesis of cryptococcosis, and he heads a research group that studies a variety of aspects of medical mycology.
Professor, Department of Internal Medicine
Wayne State University School of Medicine
Karmanos Cancer Institute
Detroit, Michigan
Pranatharthi H. Chandrasekar received a medical degree and completed an internship (including service as senior house officer) and a research fellowship in internal medicine at Christian Medical College in Vellore, India. He completed residencies in the Department of Internal Medicine at St. Francis Medical Center in Trenton, New Jersey and at the University of Louisville in Kentucky, and a fellowship in the Division of Infectious Diseases at Hahnemann University Hospital in Philadelphia, Pennsylvania. Dr Chandrasekar currently serves as Professor in the Department of Internal Medicine at
Wayne State University School of Medicine, and he is Program Director for the Infectious Diseases Fellowship Program at Wayne State University.
Dr. Chandrasekar is a Fellow of the American College of Physicians and the Infectious Diseases Society of America. He is also a member of the International Immunocompromised Host Society and the American Society for Microbiology. He has been listed in Best Doctors in America several times and is the recipient of several teaching awards.
Dr. Chandrasekar’s research interests include epidemiology of and therapy for invasive fungal and bacterial infections in immunocompromised patients, including cancer patients and bone marrow transplant recipients. He has authored numerous articles for such peer-reviewed journals as Journal of Antimicrobial Chemotherapy, Clinical Infectious Diseases, European Journal of Clinical Infection, and Bone Marrow Transplantation. In addition, Dr. Chandrasekar is a reviewer for several journals, including Archives of Internal Medicine and Antimicrobial Agents and Chemotherapy.
Associate Professor of Medicine
Emory University School of Medicine
Associate Professor of Hematology-Oncology
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia
Amelia Langston completed a medical degree at Washington University in St. Louis, Missouri. Her postdoctoral training included a residency in internal medicine at Duke University Medical Center in Durham, North Carolina and a fellowship in medical oncology at University of Washington Hospitals in Seattle. In addition to her professorships at Emory University School of Medicine and Winship Cancer Institute, Dr. Langston serves as Chief of Service, Director of the Matched Unrelated Donor Transplant Program, and Medical Director in the Bone Marrow and Stem Cell Transplant Center at Emory University School of Medicine.
Dr. Langston is a member of the American Society of Hematology, American Society of Clinical Oncology, and Immunocompromised Host Society. Additionally, she holds several administrative appointments, including Chair of the Hematology and BMT Research Working Group and the Bone Marrow and Stem Cell Transplant Center Quality Improvement Committee.
Dr. Langston's is well-published in the peer-reviewed literature, having published numerous research articles and abstracts. She has also authored several book chapters, and she is an ad hoc reviewer for Blood, Bone Marrow Transplantation, and Clinical Infectious Diseases. Dr. Langston’s research interests include novel strategies for autologous and allogeneic stem cell transplantation, the prevention and treatment of opportunistic infections in immunocompromised patients, and the use of biologically targeted agents for antileukemic therapy. She is a highly-sought invited lecturer both nationally and internationally.
Professor of Medicine
Director, Blood and Marrow Transplant Program
University of Florida Shands Cancer Center
Gainesville, Florida
John R. Wingard received a medical degree from The Johns Hopkins University School of Medicine in Baltimore, Maryland. He completed an internship and residency in internal medicine at the City of Memphis Hospital/University of Tennessee Center for Health Sciences; served as Chief Resident, Medical Service, at the V.A. Hospital in Memphis; and completed fellowships in oncology and internal medicine at The Johns Hopkins University School of Medicine. Dr. Wingard currently serves as Director of the Bone Marrow Transplant Program and Deputy Director at the University of Florida Shands Cancer Center.
A Diplomate of the American Board of Internal Medicine with a Subspecialty in Medical Oncology, Dr. Wingard counts among his many honors the Price Eminent Scholar Endowed Chair, the University of Florida Research Foundation Professorship Award, and the Faculty Research Prize for Clinical Science, awarded by the Faculty of the University of Florida College of Medicine for Outstanding Achievements and Productivity in Research. He is a member of several professional organizations and national committees, and is the Chairman of the Florida BMT Advisory Committee and Co-Chair of the Late Effects Committee of the Center for International Blood and Marrow Transplant Research. Dr. Wingard is Past President of the American Society of Blood and Marrow Transplantation.
Dr. Wingard has authored numerous articles, abstracts, and reviews, and he serves on the editorial boards of several peer-reviewed journals, including Clinical Advances in Hematology & Oncology, Transplant Infectious Disease, and Stem Cells. He is Associate Editor of Biology of Blood and Marrow Transplantation. Additionally, he has written numerous book chapters and three books: Clinical Applications of Cytokines and Growth Factors (1999), Management of Infections in Oncology Patients (2003), and Fungal Infections in the Immunocompromised Patient (2005). Dr. Wingard lectures nationally and internationally on topics relating to fungal infections and bone marrow transplantation.
|
|
|
|
|
|
|